Current marijuana use among U.S. adults in 2022 was highest in Vermont, where around 34.37 percent of adults reported using marijuana within the past year. In recent years, a number of U.S. states, including Colorado and California, have legalized the sale of marijuana for recreational use. In 2022, around 132 million people in the United States reported that they had used marijuana at least once in their lifetime.
Consumer behavior Starting around 2013, the majority of U.S. adults now say they are in favor of legalizing marijuana in the United States. The share of adults who were in favor of legalization has continued to increase over the years. As of 2021, about 68 percent of U.S. adults aged 18 and older were in favor of legalization. Legal sales of marijuana reached 16.5 billion U.S. dollars in 2021, and are expected to increase to around 37 billion dollars by the year 2026.
COVID-19 impact on marijuana use The COVID-19 pandemic and resulting lockdowns led to fears of an increase in substance abuse in many parts of the world. In March 2020, around 40 percent of millennials who used cannabis in the past year reported that they planned to increase their marijuana use during the COVID-19 pandemic. This rise in usage was reflected in sales early in the pandemic. In California for example, sales of marijuana on March 16, 2020 increased 159 percent compared to the same day in 2019.
The National Survey on Drug Use and Health (NSDUH) Perceptions of Great Risk from Smoking Cigarettes Or Marijuana dataset includes perceptions of great risk percentage from smoking one or more packs of cigarettes per day among individuals aged 12 or older and perceptions of great risk percentage from smoking marijuana once a month by State and Substate Region: Percentages, Annual Averages Based on 2012, 2013, and 2014.
Open Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
Number and percentage of people reporting cannabis use in the past three months by quarter, geography, gender, age, household population aged 15 years or older, Canada.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This directory contains data behind the story How Baby Boomers Get High. It covers 13 drugs across 17 age groups.
Source: National Survey on Drug Use and Health from the Substance Abuse and Mental Health Data Archive.
Header | Definition |
---|---|
alcohol-use | Percentage of those in an age group who used alcohol in the past 12 months |
alcohol-frequency | Median number of times a user in an age group used alcohol in the past 12 months |
marijuana-use | Percentage of those in an age group who used marijuana in the past 12 months |
marijuana-frequency | Median number of times a user in an age group used marijuana in the past 12 months |
cocaine-use | Percentage of those in an age group who used cocaine in the past 12 months |
cocaine-frequency | Median number of times a user in an age group used cocaine in the past 12 months |
crack-use | Percentage of those in an age group who used crack in the past 12 months |
crack-frequency | Median number of times a user in an age group used crack in the past 12 months |
heroin-use | Percentage of those in an age group who used heroin in the past 12 months |
heroin-frequency | Median number of times a user in an age group used heroin in the past 12 months |
hallucinogen-use | Percentage of those in an age group who used hallucinogens in the past 12 months |
hallucinogen-frequency | Median number of times a user in an age group used hallucinogens in the past 12 months |
inhalant-use | Percentage of those in an age group who used inhalants in the past 12 months |
inhalant-frequency | Median number of times a user in an age group used inhalants in the past 12 months |
pain-releiver-use | Percentage of those in an age group who used pain relievers in the past 12 months |
pain-releiver-frequency | Median number of times a user in an age group used pain relievers in the past 12 months |
oxycontin-use | Percentage of those in an age group who used oxycontin in the past 12 months |
oxycontin-frequency | Median number of times a user in an age group used oxycontin in the past 12 months |
tranquilizer-use | Percentage of those in an age group who used tranquilizer in the past 12 months |
tranquilizer-frequency | Median number of times a user in an age group used tranquilizer in the past 12 months |
stimulant-use | Percentage of those in an age group who used stimulants in the past 12 months |
stimulant-frequency | Median number of times a user in an age group used stimulants in the past 12 months |
meth-use | Percentage of those in an age group who used meth in the past 12 months |
meth-frequency | Median number of times a user in an age group used meth in the past 12 months |
sedative-use | Percentage of those in an age group who used sedatives in the past 12 months |
sedative-frequency | Median number of times a user in an age group used sedatives in the past 12 months |
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
Contains a set of data tables for each part of the Smoking, Drinking and Drug Use among Young People in England, 2021 report
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
This report contains results from the latest survey of secondary school pupils in England in years 7 to 11 (mostly aged 11 to 15), focusing on smoking, drinking and drug use. It covers a range of topics including prevalence, habits, attitudes, and wellbeing. This survey is usually run every two years, however, due to the impact that the Covid pandemic had on school opening and attendance, it was not possible to run the survey as initially planned in 2020; instead it was delivered in the 2021 school year. In 2021 additional questions were also included relating to the impact of Covid. They covered how pupil's took part in school learning in the last school year (September 2020 to July 2021), and how often pupil's met other people outside of school and home. Results of analysis covering these questions have been presented within parts of the report and associated data tables. It includes this summary report showing key findings, excel tables with more detailed outcomes, technical appendices and a data quality statement. An anonymised record level file of the underlying data on which users can carry out their own analysis will be made available via the UK Data Service later in 2022 (see link below).
EMSIndicators:The number of individual patients administered naloxone by EMSThe number of naloxone administrations by EMSThe rate of EMS calls involving naloxone administrations per 10,000 residentsData Source:The Vermont Statewide Incident Reporting Network (SIREN) is a comprehensive electronic prehospital patient care data collection, analysis, and reporting system. EMS reporting serves several important functions, including legal documentation, quality improvement initiatives, billing, and evaluation of individual and agency performance measures.Law Enforcement Indicators:The Number of law enforcement responses to accidental opioid-related non-fatal overdosesData Source:The Drug Monitoring Initiative (DMI) was established by the Vermont Intelligence Center (VIC) in an effort to combat the opioid epidemic in Vermont. It serves as a repository of drug data for Vermont and manages overdose and seizure databases. Notes:Overdose data provided in this dashboard are derived from multiple sources and should be considered preliminary and therefore subject to change. Overdoses included are those that Vermont law enforcement responded to. Law enforcement personnel do not respond to every overdose, and therefore, the numbers in this report are not representative of all overdoses in the state. The overdoses included are limited to those that are suspected to have been caused, at least in part, by opioids. Inclusion is based on law enforcement's perception and representation in Records Management Systems (RMS). All Vermont law enforcement agencies are represented, with the exception of Norwich Police Department, Hartford Police Department, and Windsor Police Department, due to RMS access. Questions regarding this dataset can be directed to the Vermont Intelligence Center at dps.vicdrugs@vermont.gov.Overdoses Indicators:The number of accidental and undetermined opioid-related deathsThe number of accidental and undetermined opioid-related deaths with cocaine involvementThe percent of accidental and undetermined opioid-related deaths with cocaine involvementThe rate of accidental and undetermined opioid-related deathsThe rate of heroin nonfatal overdose per 10,000 ED visitsThe rate of opioid nonfatal overdose per 10,000 ED visitsThe rate of stimulant nonfatal overdose per 10,000 ED visitsData Source:Vermont requires towns to report all births, marriages, and deaths. These records, particularly birth and death records are used to study and monitor the health of a population. Deaths are reported via the Electronic Death Registration System. Vermont publishes annual Vital Statistics reports.The Electronic Surveillance System for the Early Notification of Community-based Epidemics (ESSENCE) captures and analyzes recent Emergency Department visit data for trends and signals of abnormal activity that may indicate the occurrence of significant public health events.Population Health Indicators:The percent of adolescents in grades 6-8 who used marijuana in the past 30 daysThe percent of adolescents in grades 9-12 who used marijuana in the past 30 daysThe percent of adolescents in grades 9-12 who drank any alcohol in the past 30 daysThe percent of adolescents in grades 9-12 who binge drank in the past 30 daysThe percent of adolescents in grades 9-12 who misused any prescription medications in the past 30 daysThe percent of adults who consumed alcohol in the past 30 daysThe percent of adults who binge drank in the past 30 daysThe percent of adults who used marijuana in the past 30 daysData Sources:The Vermont Youth Risk Behavior Survey (YRBS) is part of a national school-based surveillance system conducted by the Centers for Disease Control and Prevention (CDC). The YRBS monitors health risk behaviors that contribute to the leading causes of death and disability among youth and young adults.The Behavioral Risk Factor Surveillance System (BRFSS) is a telephone survey conducted annually among adults 18 and older. The Vermont BRFSS is completed by the Vermont Department of Health in collaboration with the Centers for Disease Control and Prevention (CDC).Notes:Prevalence estimates and trends for the 2021 Vermont YRBS were likely impacted by significant factors unique to 2021, including the COVID-19 pandemic and the delay of the survey administration period resulting in a younger population completing the survey. Students who participated in the 2021 YRBS may have had a different educational and social experience compared to previous participants. Disruptions, including remote learning, lack of social interactions, and extracurricular activities, are likely reflected in the survey results. As a result, no trend data is included in the 2021 report and caution should be used when interpreting and comparing the 2021 results to other years.The Vermont Department of Health (VDH) seeks to promote destigmatizing and equitable language. While the VDH uses the term "cannabis" to reflect updated terminology, the data sources referenced in this data brief use the term "marijuana" to refer to cannabis. Prescription Drugs Indicators:The average daily MMEThe average day's supplyThe average day's supply for opioid analgesic prescriptionsThe number of prescriptionsThe percent of the population receiving at least one prescriptionThe percent of prescriptionsThe proportion of opioid analgesic prescriptionsThe rate of prescriptions per 100 residentsData Source:The Vermont Prescription Monitoring System (VPMS) is an electronic data system that collects information on Schedule II-IV controlled substance prescriptions dispensed by pharmacies. VPMS proactively safeguards public health and safety while supporting the appropriate use of controlled substances. The program helps healthcare providers improve patient care. VPMS data is also a health statistics tool that is used to monitor statewide trends in the dispensing of prescriptions.Treatment Indicators:The number of times a new substance use disorder is diagnosed (Medicaid recipients index events)The number of times substance use disorder treatment is started within 14 days of diagnosis (Medicaid recipients initiation events)The number of times two or more treatment services are provided within 34 days of starting treatment (Medicaid recipients engagement events)The percent of times substance use disorder treatment is started within 14 days of diagnosis (Medicaid recipients initiation rate)The percent of times two or more treatment services are provided within 34 days of starting treatment (Medicaid recipients engagement rate)The MOUD treatment rate per 10,000 peopleThe number of people who received MOUD treatmentData Source:Vermont Medicaid ClaimsThe Vermont Prescription Monitoring System (VPMS)Substance Abuse Treatment Information System (SATIS)
Open Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
Number and percentage of people reporting cannabis use in the past three months by quarter, geography, gender, age, household population aged 15 years or older, Canada.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Current marijuana use among U.S. adults in 2022 was highest in Vermont, where around 34.37 percent of adults reported using marijuana within the past year. In recent years, a number of U.S. states, including Colorado and California, have legalized the sale of marijuana for recreational use. In 2022, around 132 million people in the United States reported that they had used marijuana at least once in their lifetime.
Consumer behavior Starting around 2013, the majority of U.S. adults now say they are in favor of legalizing marijuana in the United States. The share of adults who were in favor of legalization has continued to increase over the years. As of 2021, about 68 percent of U.S. adults aged 18 and older were in favor of legalization. Legal sales of marijuana reached 16.5 billion U.S. dollars in 2021, and are expected to increase to around 37 billion dollars by the year 2026.
COVID-19 impact on marijuana use The COVID-19 pandemic and resulting lockdowns led to fears of an increase in substance abuse in many parts of the world. In March 2020, around 40 percent of millennials who used cannabis in the past year reported that they planned to increase their marijuana use during the COVID-19 pandemic. This rise in usage was reflected in sales early in the pandemic. In California for example, sales of marijuana on March 16, 2020 increased 159 percent compared to the same day in 2019.